Table 4

One-way ANOVA (Bonferroni) analysis of the Se levels

n
 mean
 S.D.
 SEM
 95% confidence interval
 minimum
 maximum
 p-value vs controls







low
 high


Controls
 554
 90,49
 20,85
 0,89
 88,75
 92,23
 47,34
 187,20
Ski jumpers
 24
 83,17
 26,51
 5,41
 71,97
 94,36
 51,30
 136,00
 1
Ski runners
 109
 86,59
 21,04
 2,02
 82,60
 90,59
 45,82
 165,00
 1
Children hypothyroidism
 47
 81,98
 22,53
 3,29
 75,36
 88,59
 41,30
 131,00
 1
Children Hashimoto
 28
 77,40
 23,54
 4,45
 68,27
 86,53
 40,50
 119,30
 0,308
Children hyperthyroidism
 4
 65,95
 13,99
 6,99
 43,69
 88,21
 53,40
 81,00
 1
Children polyendocrinopathy
 6
 66,93
 20,92
 8,54
 44,98
 88,89
 43,70
 96,20
 1
Thyroid normal adults
 283
 81,06
 21,62
 1,29
 78,53
 83,59
 30,10
 172,80
 < 0,001
Thyroid immunogenic adults
 131
 81,98
 24,82
 2,17
 77,69
 86,27
 28,50
 163,00
 0,009
Subacute thyroiditis adults
 25
 66,35
 23,13
 4,63
 56,81
 75,90
 31,30
 119,40
 < 0,001
Silent thyroiditis adults
 26
 59,28
 20,13
 3,95
 51,15
 67,42
 20,70
 96,90
 < 0,001
anaplastic Ca
 3
 95,00
 13,25
 7,65
 62,08
 127,92
 87,35
 110,30
 1
follicular Ca
 42
 76,89
 21,16
 3,26
 70,30
 83,49
 47,38
 124,00
 0,015
foll papillary Ca
 11
 68,85
 18,57
 5,60
 56,37
 81,33
 46,84
 96,77
 0,176
giant cell papillary Ca
 10
 83,69
 26,88
 8,50
 64,46
 102,91
 51,10
 113,40
 1
invasive Ca
 8
 74,80
 18,28
 6,46
 59,51
 90,08
 60,68
 103,10
 1
microcarcinoma
 4
 68,10
 9,54
 4,77
 52,91
 83,28
 59,83
 76,36
 1
papillary Ca
 73
 80,40
 19,87
 2,33
 75,77
 85,04
 50,72
 121,80
 0,031
unclassified Ca
 13
 75,91
 20,72
 5,75
 63,38
 88,43
 47,38
 110,30
 1
All
 1401
 84,20
 22,50
 0,60
 83,02
 85,38
 20,70
 187,20

Moncayo et al. BMC Endocrine Disorders 2008 8:2   doi:10.1186/1472-6823-8-2